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Edited by Lukas HuberAbstract Mutations in components of the Wnt/b-catenin path-
way are observed to be the earliest initiating event for most colo-
rectal tumors. The majority of the mutations occur in the tumor
suppressor adenomatous polyposis coli (APC), even though there
are other genes that are capable of modulating the pathway
activity. Moreover, the speciﬁc APC mutations associated in co-
lon cancer indicate the possibility that the tumor selects for cer-
tain truncated forms of APC that partially retain its function,
namely, inhibition of b-catenin. We estimated the eﬀects of var-
ious mutations in APC and other known mutations using a recent
mathematical model of the Wnt pathway that was constructed to
represent the conserved core molecular events. We provide evi-
dence that APC mutations are selected not based on the maximal
level of b-catenin but rather based on distinct state of activity
that appears to be optimal for the tissue-speciﬁc tumorigenesis.
This optimal level is determined by balancing b-catenin signaling
and the induction of Axin2 that acts as a potent negative feed-
back. The predominant pattern of APC mutations may provide
synergistic oncogenic eﬀects that promote colorectal tumorigen-
esis: the optimal signaling for cell survival and renewal, disrupted
cell adhesion, chromosomal instability, and altered asymmetric
division of stem cells.
 2006 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Colorectal cancer represents a relatively well-characterized
tumorigenesis paradigm. Mutations in the adenomatous pol-
yposis coli (APC) gene have been identiﬁed as the initiating
event both in the inherited and the spontaneous form of theAbbreviations: APC, adenomatous polyposis coli; Dsh, disheveled;
GSK3b, glycogen synthase kinase 3b; TCF, T cell factor
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are disrupted, its ability to regulate the Wnt pathway is lost as
well as its other cellular functions. As a result, the transcrip-
tional eﬀector b-catenin is activated to contribute to the
tumorigenesis. Yet this classic description of a tumor suppres-
sor function does not fully explain the observed link between
the observed APC mutations and tumorigenesis. First, if the
elevated activity of b-catenin is the major requirement for can-
cer initiation, other regulators of the pathway also have the po-
tential to cause aberrant signaling when their genes are
mutated. However, the observed cases of colon cancer muta-
tions in this pathway are predominantly on APC and rarely
on the other molecules [3]. Second, detailed analysis of the
common mutations seen in the ﬁrst and the second inactivated
alleles of APC indicates a preference for certain truncation
mutation combinations [1,2,4]. It is not clear if the selective
advantage conferred by these preferred mutations is solely in
terms of their eﬀect on Wnt/b-catenin signaling.
Wnt/b-catenin pathway is a conserved molecular system that
plays a major role in development and homeostatic tissue self-
renewal. In a resting state, b-catenin level remains low due to
constant turnover mostly by the destruction complex APC/
Axin/GSK3b. Phosphorylation by this complex causes b-cate-
nin to be degraded by the proteasome. When the Wnt binds to
the cell surface receptor Frizzled and activates disheveled
(Dsh), glycogen synthase kinase 3b (GSK3b) is dissociated
from the destruction complex. As a result, free b-catenin accu-
mulates and translocates into the nucleus. There b-catenin
binds to T cell factor (TCF) releasing it from a repressed state
and initiates transcription of its target genes. c-myc, cyclin D1,
MMP7, and CD44 are some of the known target genes that
may be relevant for a tumor. Fig. 1 shows major interactions
in the pathway.
Examining the frequent mutations in APC in the context of
its functional sites has provided some insight about what could
be important for the early events in tumor. The large structure
of the APC gene contains important regions for its function in
b-catenin signaling as well as other domains whose functions
have been characterized better recently (see Fig. 2 and [5]).
The region that is most frequently mutated to produce the
most common truncated mutant of APC in cancer is the so-
matic mutation hotspot between codons 1286 and 1513. Inter-
estingly, analysis of ﬁrst (germline) and second (somatic)
mutation patterns shows that if the ﬁrst mutation was in theation of European Biochemical Societies.
Fig. 1. The Wnt pathway model. The molecular interactions represented in the quantitative model are depicted schematically in this diagram.
Arrows correspond to reactions speciﬁed by their numbers in the diﬀerential equations model (see Table S1). Reaction 18 was added to the original
model constructed by Lee et al. The multi-molecular complexes shown are simpliﬁed and do not reﬂect their structural contacts.
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gosity and if the ﬁrst lies outside the hotspot, the second invari-
ably occurs in this region. This underscores the strong selection
pressure to produce this particular mutant APC over other
possible mutants. Therefore it was recently suggested that
tissue-speciﬁc tumorigenesis might require the ‘right’ level of
b-catenin signaling [2]. Discerning such subtle quantitative dif-
ferences in an in vivo system is often impossible due to the
highly controlled manipulations and the level of detection
accuracy necessary. Moreover, relating speciﬁc mutations into
quantiﬁable signaling outcome in the context of the intercon-
nected network structure of the pathway is far from intuitive
[6].
Here we used a recently constructed quantitative model of
Wnt/b-catenin signaling pathway to examine the eﬀects of
various mutations observed in colorectal cancer. Ethan Lee
and his colleagues used a Xenopus egg extract system to obtain
relatively accurate biochemical measurements and recon-
structed the core conserved pathway with a set of diﬀerential
equations [7]. The resulting quantitative model represents the
major molecular reactions in the Wnt pathway. The speciﬁc
reactions included in our adaptation of their model are shown
in Fig. 1. We compared features of signaling outcome caused
by frequent versus rare mutations to discern the important fea-
tures that are selected by the tumor. We also estimated the
eﬀects of incremental loss of APC sites that interact with other
pathway components and the eﬀects of the rare mutations of
Axin and b-catenin. APC/Axin independent degradationmechanism and its tissue-speciﬁc activity were simulated also
to assess its potential role in tumor risk.
Our major adjustment on the Lee model was inclusion of the
negative feedback provided by b-catenin/TCF-induced synthe-
sis of Axin2. The original model was based on an in vitro cyto-
plasmic extract system. Therefore it would be more appropriate
to consider this induction phenomenon to better approximate
the intact eukaryotic cell. Axin2 is a direct transcriptional tar-
get of b-catenin/TCF and is known to be over-expressed in cells
with activated b-catenin/TCF [8–10]. The full model is shown in
Table S1.2. Methods
2.1. Speciﬁcation and adjustment of the Wnt pathway model
We employed the model developed by Lee et al. which was derived
from quantitative biochemical measurements on a Xenopus egg extract
system [7,11]. This model represents the cytoplasmic part of the con-
served pathway, therefore not including membrane or nuclear events
explicitly. We did not use the approximations based on the assumed
fast binding reactions. We used the full model instead because, for
the pathway altered by mutated system components, it is not clear
whether these approximations may hold true. Each model was simu-
lated by solving the corresponding diﬀerential equations using the
computational software MATLAB and its stiﬀ ODE solver ‘ode15s’.
All our simulations were run in the absence of Wnt (W = 0) to model
the cancer cells that do not rely on extracellular Wnt availability. Start-
ing from the initial condition given by the steady state of the wild type
model for W = 0, a new steady state was obtained for each simulation.
Fig. 2. The truncated APC mutants. The APC protein and its incrementally truncated forms are shown (not to exact scale). They represent all
possible truncations in terms of their binding site composition. The number describing each binding site corresponds to the reaction in which it
participates in our quantitative model. APC has other known functional sites that are important for diverse cellular functions and they are not shown
here. APC m7, m8, and m9 are generated by mutations frequently observed in colorectal cancer.
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the well-established observation that b-catenin/TCF directly induces
the axin2 gene. In our model, Axin1 and Axin2 are combined into
‘Axin’ because their function is believed to be largely equivalent. The
introduced Axin2 synthesis term is set to have a range of small values
so that the overall Axin (1 and 2) concentration remains in the similar
low range as in the original model (see Table S1). Since an accurate
measurement of this synthesis rate is not available, we also varied this
rate constant and conﬁrmed that our qualitative conclusions are not
aﬀected by speciﬁc values of this parameter.
As another adjustment to Xenopus egg extract-based measurements,
we needed to re-assess the binding reaction of b-catenin and TCF,
which, for intact eukaryotic cells, occurs mainly in the nucleus. In that
case, the binding of b-catenin to TCF would take more time due to
translocation into the nucleus. For this reason the concentration values
of b-catenin/TCF that the original model produces are inadequate for
a measure of signaling output in a cancer cell. However, instead of
changing the relevant rate constant values (for the nuclear import of
b-catenin and binding to TCF) that are unknown and may be cell-type
speciﬁc, we simply combined the two molecular species b-catenin and
b-catenin/TCF and termed them ‘available b-catenin’. This represents
the pool of b-catenin that is available for nuclear translocation and
binding to TCF or other transcriptional eﬀectors. We take this quan-
tity to be our signaling output. In equilibrium, the actual b-catenin/
TCF complex is proportional to the concentration of the available b-
catenin.2.2. Representation of the various mutations in the simulations
The structure of the APC gene allows a series of possible trunca-
tion mutations determined by their 3 0 end. Depending on where the
truncation occurs in the mutant, the functional sites retained or lost
are determined. In the signaling network, this means that some reac-
tions are completely lost whereas others are maintained partially. We
set the reactions 17 (binding of APC to b-catenin), eight (incorpora-
tion of b-catenin into the destruction cycle), and seven (binding of
APC to Axin) to be those that are aﬀected by the 15 amino acid re-
peat binding sites for b-catenin, 20 amino acid binding sites for b-
catenin degradation, and SAMP repeat sites for Axin binding,
respectively. This is because both of the b-catenin binding sites inAPC bind b-catenin but only the 20 amino acid sites correlate with
the downregulation of b-catenin through formation of the destruc-
tion complex [1].
We determined the parameter values in the full pathway model for
the wild type and the mutations as follows. We ﬁxed k+ for reactions 7,
8, 16, and 17 to be 1. Then their dissociation rates k for the wild type
are 50, 120, 30, and 1200, respectively, by the formula K = k/k+. To
obtain k(X) for mutant proteins with X number of binding sites, we
ﬁrst deﬁned the contribution k 0 from acquiring a single binding site
out of XWT (the number of binding sites in the wild type protein):
k ¼ kmax  k0XWT where we assume kmax is the maximal dissociation
rate. The highest possible value for the dissociation rate is likely to
be constrained by the physicochemical composition of the cytoplasm.
We set kmax = 2000 which is large enough in the numerical range of
our parameter values. Using the value of k 0 determined by the above
formula for k, we obtain k(X) = kmax Æ k
0X for a mutant protein with
only X binding sites. That is, for every lost binding site in the trun-
cated protein, the dissociation increases by a multiplicative increment
(k 0)1. We reasoned that loss of each tandem repeat would aﬀect the
free energy change associated with the binding reaction by an equal
amount. Although this may not accurately reﬂect the higher level
changes in aﬃnity which may come from allosteric features, we chose
the simple relationship between the number of binding sites and bind-
ing aﬃnity, given the lack of detailed binding data on the various APC
mutants. The Axin mutation was modeled by setting k8 (dissociation
of b-catenin from the destruction cycle) = kmax. This is because the
reaction 8 requires both Axin and APC and therefore without the
Axin scaﬀold there would be maximal dissociation. b-catenin mutation
was implemented by setting k9 (phosphorylation of b-catenin) = 0.
For the variation simulations corresponding to the diﬀerent rates of
Axin-independent degradation of b-catenin, we varied k13 by 1/4, 1/2,
2, 4-fold. All simulations were run up to t = 10000 min.3. Results and discussion
We have examined the altered dynamic states by introducing
a series of APC truncation mutants in the computational
3668 K.-H. Cho et al. / FEBS Letters 580 (2006) 3665–3670model. Speciﬁcally, one of the three molecules was mutated:
APC, Axin, or b-catenin, in each situation. The read-out of
the signaling activity in our model is the available b-catenin.
This represents the pool of b-catenin that is not captured in
the destruction core cycle (see Fig. 1). In the absence of
Wnt, the steady state level of the available b-catenin is low.
Mutations that disrupt the degradation of b-catenin, however,
elevate the available b-catenin that can bind TCF and activate
its target gene transcription. In all simulations, the concentra-
tion of Wnt was set to zero to model the eﬀects of mutations in
cancer cells that do not rely on extracellular Wnt. For each
mutation, we simulated the model by computationally solving
the diﬀerential equations with altered parameter values corre-
sponding to the speciﬁc form of APC, Axin, or b-catenin. Sim-
ulations were run until the system reached a steady state and
the ﬁnal concentration of the available b-catenin was obtained
for each simulated mutation.
The APC mutations that we considered are shown in Fig. 2
and the corresponding altered steady state levels of b-catenin/
TCF are shown in Fig. 3. Among colorectal cancer-related
mutations in the APC gene, the most common truncations re-
tain all three 15 amino acid b-catenin binding sites and one
or two 20 amino acid repeats, but none of the Axin binding
sites. There are numerous other possible truncations and the
corresponding protein products have a distinct set of func-
tional sites. These truncated APC proteins, in turn, must have
diﬀerent binding reaction kinetics with the partner molecules.
We considered all possible truncations and organized them
according to the presence/absence of individual functional
sites. Table S2 shows the mutations and the corresponding
parameter values that were altered from the reference model
to represent the mutational eﬀects on the relevant reactions.
These values were calculated by approximating the loss of
each binding site to correspond to a gradual increase in theFig. 3. The eﬀects of individual mutations on b-catenin signaling output
component was mutated, APC (‘m1’–‘m13’), Axin (‘Axin’), or b-catenin (‘Bet
available b-catenin for nuclear translocation and transcriptional activation.
‘m13’ correspond to APC mutants listed in Fig. 2. The Axin mutation produ
domains. The b-catenin mutation allows it to escape phosphorylation by GSdissociation rate (k) such that complete loss renders the rate
to reach a preset maximum value. Since the forward associa-
tion rate (k+) is mostly determined by diﬀusion, it is probably
independent of the number of binding sites within the pro-
teins. Therefore we reasoned that it is the dissociation rate
that depends on the binding sites. Furthermore, in the ab-
sence of detailed information about cooperativity of the mul-
tiple binding sites, we took equal contribution from each site.
To see the diﬀerence between the frequently observed APC
mutations and other rare mutations of the Wnt pathway in
colorectal cancer, two additional genes were considered. Axin
mutations have been reported to produce a truncated protein
that lacks the domains for b-catenin binding and Dsh binding
[3]. Most b-catenin mutations target the amino acids that are
phosphorylated by GSK3b, thereby escaping the destruction
core cycle. These situations were implemented by changing
the rate constants of the reactions aﬀected by the speciﬁc
mutations (see Table S2).
There was a clear diﬀerence in b-catenin signaling state
resulting from the APC, Axin, and b-catenin mutations. The
b-catenin mutation resulted in the highest level of b-catenin be-
cause it completely blocks the Axin-dependent degradation.
This level could serve as a positive control in our simulations.
The Axin mutation signiﬁcantly elevated the signaling com-
pared to the wild type level but was not as eﬃcient as the other
mutations in inhibiting the destruction core cycle. APC muta-
tions ranged between the minimum and the maximum set by
the Axin and the b-catenin mutations, respectively. Impor-
tantly, none of the mutant APCs could achieve the maximal le-
vel of eﬃciency in increasing b-catenin signaling.
We note that the APC mutations that are most common in
colorectal cancer produce the mutants APC m7, m8, and m9.
The other mutants correlate with diﬀerent disease severity and
progression (‘attenuated’ cancer) or tumor occurrence at diﬀer-. Each simulation corresponds to the situation where one pathway
a’). The signaling output is measured by the steady state amount of the
‘WT’ shows the output in the original pathway model. ‘m1’ through
ces the protein that lacks the b-catenin binding and Disheveled binding
K3b.
Fig. 4. The mutational eﬀects in the context of various levels of Axin-independent degradation of b-catenin. The circled solid curve represents the
original result identical to Fig. 3. Axin-independent degradation of b-catenin was changed by multiplying the original degradation rate constant by
1/4, 1/2, 2, and 4. The resulting curves are labeled by black inverse triangle, white inverse triangle, white triangle, and black triangle for 1/4, 1/2, 2,
and 4, respectively. Each point shows the available b-catenin level at t = 10000 min.
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observed in colorectal cancer. Our analysis suggests that the
particular APC mutations that are preferred in colorectal can-
cer seem to result in mid-range signaling activity of b-catenin.
The other mutations result in higher (b-catenin mutant, APC
m10–m13) or lower (APC m1–m6, Axin mutant) level of
b-catenin. We note a qualitative agreement between our results
and reported changes in b-catenin levels for some APC mu-
tants [6]. The reversed trend around APC m10 suggests that
there might be an optimal activity of APC in promoting the
degradation of b-catenin. Complete loss of this function of
APC results in higher transcriptional activity of the b-cate-
nin/TCF at the axin2 gene. The newly synthesized Axin2 par-
ticipates in the degradation of b-catenin. Therefore the cancer
cell beneﬁts by striking a balance between the levels of b-cate-
nin and Axin2.
Axin-independent degradation of b-catenin has been pro-
posed as a mechanism for tissue speciﬁcity of APC mutations
[7]. So we varied k13 to mimic the activity level of Axin-inde-
pendent degradation in diﬀerent tissues (see Fig. 4). As ex-
pected, the signaling outcome of the various mutations
depends on the rate of Axin-independent degradation of
b-catenin in the resident tissue. The more active this alternative
degradation mechanism is, the more similar becomes the level
of b-catenin signaling in the diﬀerent mutated systems. In par-
ticular, APC mutations no longer exhibit the distinct mid-
range signaling and are indistinguishable from the other two
mutations. In this situation, the APC mutations may not have
any selection advantage for the cancer cells over Axin and
b-catenin mutations. This may explain in part why APC muta-
tions are preferred in certain cancers including colorectal can-
cer, whereas APC, Axin, and b-catenin mutations all seem to
have an equivalent eﬀect of deregulating the pathway in
cancers of other tissues [3].We acknowledge that analysis with quantitative models
gives us an approximation of the cellular behavior, as most
technical approaches do for probing signal transduction in liv-
ing cells. Yet it permits us to relate the known molecular inter-
action network to the overall system behavior and it also
provides reasonable estimates useful for generating further
hypotheses. To address the variability of the system behavior
dependent on speciﬁc parameter values in a systematic man-
ner, we are conducting a multi-parameter sensitivity analysis
on this pathway (manuscript in preparation). Another advan-
tage of analyzing mutation phenotypes in silico is the precise
control of comparison experiments against the wild type. In
transfection experiments using mutant plasmids, it is often
technically impossible to replace the endogenous protein com-
pletely by the exogenous mutant while maintaining the same
overall expression proﬁle as in the wild type cells. The gene
may not allow generation of knockout cell lines into which
the mutant could be introduced. Even if the knockout line is
available, their intracellular molecular composition is probably
diﬀerent from the parental cells because of various compensa-
tory cellular mechanisms. This may complicate the interpreta-
tion of some in vivo data on direct comparison of wild type
and mutant phenotypes in signal transduction. Comparison
of pathway behavior in an in silico system enables us to assess
the expected phenotype when everything else is exactly the
same except that the wild type protein has been substituted
by the mutant. We have also examined the situation where
both the wild type and the mutant alleles are expressed in equal
concentration. The overall results were very similar to those
obtained above from one allele only (data not shown).
We note that the present study has focused on the function
of APC in the Wnt signaling pathway. But the diverse func-
tions of APC have been documented by numerous observa-
tions about its dynamic cellular localization and association
3670 K.-H. Cho et al. / FEBS Letters 580 (2006) 3665–3670with a heterogeneous group of factors. It is possible that there
exist diﬀerent populations of APC participating in diﬀerent cel-
lular processes in parallel. These functionally assigned APC
species may diﬀer in their concentration range by orders of
magnitude. If, for example, the sensitivity of an experimental
assay permitted about a 10-fold variation (an order of magni-
tude in dynamic range), then only a subset of these species
might be detected. It is noteworthy that in our analysis it takes
only a tiny amount of APC for the destruction core cycle to
work. The rest (and most) of the APC seems to be available
for other potential functions.
It is interesting in this regard to note the other recently dis-
covered functions of APC. APC was shown to function during
mitosis to ensure correct segregation of chromosomes [5,12].
Deletion of the relevant C-terminal domain produces chromo-
somal instability which is a hallmark of many types of cancer.
APC is also involved in asymmetric division of the stem cells in
physical contact with their niche in a Drosophila system [13].
Asymmetric division of a stem cell is a critical event that en-
sures homeostasis of the colon. Deregulated division of stem
cells may shift the normal turnover of crypt cells toward higher
net growth, eventually leading to colorectal cancer [14]. If the
cellular process similar to the Drosophila system is relevant in
human, this provides additional explanation for the prominent
status of APC as a tumor suppressor.
Our analysis results support the idea that maximal b-catenin
signaling cannot explain the observed predominant mutations
of APC in colorectal cancer. Rather, cancer cells are likely to
prefer the ‘right’ level of b-catenin signaling in the presence
of the negative feedback by a potent regulator Axin2. This
optimal activity is also determined in part by the tissue-speciﬁc
level of the Axin-independent degradation of b-catenin. Colo-
rectal cancer may prefer APC (to the other pathway compo-
nents) and the particular APC mutations due to its
synergistic eﬀect of the optimal survival signal, chromosomal
instability, and disrupted asymmetric division upon which
the tumor can evolve into full malignancy.
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